Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1963 2
1965 5
1967 3
1968 1
1969 2
1970 1
1973 2
1975 1
1977 1
1982 1
1983 2
1984 2
1985 4
1986 3
1987 1
1988 2
1989 2
1990 3
1991 4
1992 6
1993 5
1994 8
1995 4
1996 6
1997 8
1998 6
1999 7
2000 6
2001 5
2002 3
2003 1
2004 4
2005 5
2006 6
2007 7
2008 5
2009 12
2010 9
2011 13
2012 14
2013 7
2014 6
2015 14
2016 16
2017 6
2018 12
2019 21
2020 18
2021 21
2022 17
2023 5
2024 13
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Chemical composition and health properties of coffee and coffee by-products.
de Melo Pereira GV, de Carvalho Neto DP, Magalhães Júnior AI, do Prado FG, Pagnoncelli MGB, Karp SG, Soccol CR. de Melo Pereira GV, et al. Among authors: karp sg. Adv Food Nutr Res. 2020;91:65-96. doi: 10.1016/bs.afnr.2019.10.002. Epub 2020 Jan 11. Adv Food Nutr Res. 2020. PMID: 32035601 Review.
Reply.
Lynch RJ, Ye F, Sheng Q, Zhao Z, Karp SJ. Lynch RJ, et al. Among authors: karp sj. Liver Transpl. 2019 Jun;25(6):971-973. doi: 10.1002/lt.25480. Liver Transpl. 2019. PMID: 31038786 No abstract available.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators. James ND, et al. Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A. Boileau JF, et al. Among authors: karp se. J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452445 Clinical Trial.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
Disease Modeling with Kidney Organoids.
Karp S, Pollak MR, Subramanian B. Karp S, et al. Micromachines (Basel). 2022 Aug 25;13(9):1384. doi: 10.3390/mi13091384. Micromachines (Basel). 2022. PMID: 36144007 Free PMC article. Review.
COVID-19 and transplantation-Data censoring.
Subramanian V, Anderson C, Karp S, Pastan S, Gerber D, Locke J, Cohen A, Shah M, Casingal V, Strata R, Singh N, DuBay D, Dhanireddy K. Subramanian V, et al. Among authors: karp s. Am J Transplant. 2022 Aug;22(8):1958-1962. doi: 10.1111/ajt.17065. Epub 2022 Apr 28. Am J Transplant. 2022. PMID: 35451211 Free PMC article.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Uterine Transplant-Progress, but Concerns Remain.
Forbes RC, Karp S. Forbes RC, et al. Among authors: karp s. JAMA Surg. 2022 Sep 1;157(9):797-798. doi: 10.1001/jamasurg.2022.2652. JAMA Surg. 2022. PMID: 35793122 No abstract available.
313 results